IRIS PubliCatt

Agnes, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.831
NA - Nord America 4.617
AS - Asia 1.062
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 16
AF - Africa 11
OC - Oceania 10
Totale 10.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.583
DE - Germania 1.763
SE - Svezia 895
CN - Cina 756
UA - Ucraina 592
IT - Italia 427
IE - Irlanda 282
FR - Francia 244
GB - Regno Unito 176
FI - Finlandia 165
PL - Polonia 157
IN - India 83
TR - Turchia 75
BE - Belgio 48
IR - Iran 30
HK - Hong Kong 26
SG - Singapore 24
KR - Corea 23
JP - Giappone 21
CA - Canada 19
RU - Federazione Russa 14
EU - Europa 13
CH - Svizzera 12
MX - Messico 12
AU - Australia 9
CI - Costa d'Avorio 9
BR - Brasile 8
CZ - Repubblica Ceca 8
NL - Olanda 8
RO - Romania 7
ES - Italia 6
PT - Portogallo 6
VN - Vietnam 5
BG - Bulgaria 4
CL - Cile 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
EE - Estonia 3
GR - Grecia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
EC - Ecuador 2
ID - Indonesia 2
LT - Lituania 2
MD - Moldavia 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
AZ - Azerbaigian 1
BZ - Belize 1
CO - Colombia 1
DO - Repubblica Dominicana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 10.565
Salva come PNG Salva come JPEG
Città #
Chandler 979
Ashburn 416
Jacksonville 338
Dublin 275
San Mateo 269
Ann Arbor 195
Nanjing 184
New York 125
Warsaw 122
Wilmington 118
Boston 117
Nürnberg 112
Woodbridge 111
Marseille 103
Dearborn 91
Lawrence 89
Seattle 85
Bremen 82
Redwood City 81
Cattolica 76
Beijing 69
Nanchang 69
Houston 68
Rome 67
Izmir 66
Fairfield 57
Shenyang 56
Helsinki 55
Hangzhou 54
Milan 54
Princeton 53
Chicago 50
Lancaster 47
Munich 46
Brussels 44
Hebei 42
Zhengzhou 42
University Park 38
Augusta 33
Detroit 33
Mountain View 33
Andover 32
Tianjin 28
Changsha 27
Kunming 26
Norwalk 26
Shanghai 22
Hong Kong 20
Jiaxing 19
Jinan 18
Kish 18
Chengdu 17
Cambridge 16
Leawood 16
Ningbo 15
Pune 15
Fremont 14
Guangzhou 14
Hounslow 14
Boardman 13
Kraków 13
London 12
Los Angeles 12
San Giovanni Bianco 12
Washington 11
Hefei 10
Abidjan 9
Segrate 9
Seongnam 9
Lanzhou 8
Mcallen 7
San Diego 7
Seoul 7
Singapore 7
Ardabil 6
Buffalo 6
Mexico City 6
Santa Maria 6
São Paulo 6
Tokyo 6
Ypsilanti 6
Baotou 5
Berlin 5
Changchun 5
Costa Mesa 5
Monmouth Junction 5
Phoenix 5
Redmond 5
Taizhou 5
Zurich 5
Antwerpen 4
Fuzhou 4
Hanoi 4
Hanover 4
Mumbai 4
Padova 4
Portland 4
Ravenna 4
Simi Valley 4
Toronto 4
Totale 5.674
Salva come PNG Salva come JPEG
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 290
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 200
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 192
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 176
Duplex Doppler in the postoperative monitoring of liver transplant recipients 153
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 144
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 136
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 135
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 133
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 133
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 127
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 126
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 126
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 111
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 110
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 110
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 109
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 104
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 102
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 100
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 98
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 97
Psychological risk factors for graft rejection among liver transplant recipients 96
Model for end-stage liver disease dynamic stratification of survival benefit 96
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 96
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 94
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 93
Prediction of 6-month survival after liver transplantation using Cox regression. 92
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 92
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 91
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 91
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 88
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 87
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 87
Psychological risk factors for graft rejection among liver transplant recipients 87
Fungal infections after liver transplantation: incidence and outcome 86
Liver transplantation in patients with alcoholic liver disease: A retrospective study 86
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 85
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 85
Prediction of 6-month survival after liver transplantation using Cox regression 84
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 83
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 82
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 82
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 81
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 80
Lamivudine-induced muscle mitochondrial toxicity 79
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 78
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 78
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 77
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 77
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 77
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 76
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 76
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 76
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 74
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 73
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 73
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 73
Pancreatic function assessment 73
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 73
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 72
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 71
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 71
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 70
Primary difunction after liver trasplantation: donor or recipients fault? 70
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 70
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 69
Overextended Criteria Donors: Experience of an Italian Transplantation Center 69
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 67
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 66
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 66
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 66
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 65
Is primary nonfunction still a suitable indication for liver retransplantation? 65
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 65
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 65
Celiac axis compression syndrome in liver transplantation 64
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 64
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 63
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 62
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 61
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 60
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 59
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 59
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 57
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 57
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 56
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 56
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 56
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 56
Should retransplantation still be considered for primary non-function after liver transplantation? 55
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 55
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 55
Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011 55
Recovery index: a useful tool for quantification of liver injury after liver transplantation to predict one-year survival 54
Doppler ultrasonographic evaluation of the early changes in renal resistive index in cirrhotic patients undergoing liver transplantation 54
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 54
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 54
Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study 54
Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation. 52
Totale 8.628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019241 0 0 0 0 0 0 0 0 0 0 109 132
2019/20201.512 305 72 88 71 114 125 143 67 121 127 150 129
2020/20211.210 80 125 16 120 177 53 136 19 145 76 239 24
2021/20221.440 84 185 28 104 70 47 10 257 61 83 196 315
2022/20232.789 319 361 258 432 180 360 148 207 305 70 119 30
2023/20241.095 54 426 39 146 58 176 89 43 16 48 0 0
Totale 10.695